Nanoscale drug-delivery capsules that release their therapeutic cargo when triggered by a temperature change could boost the efficacy and reduce the side effects of many drugs.
Researchers at RIKEN have combined lipids and peptides to create capsules with temperature-responsive controlled release behavior (Journal of the American Chemical Society, “Spontaneous formation of gating lipid domain in uniform-size peptide vesicles for controlled release”). The hybrid capsules combine the advantages of each material to enhance both capsule stability and controlled release.
Although many experimental drug-delivery capsules, or ‘vesicles’, have been developed recently, several hurdles still have to be overcome before they can be widely used in the real world, explains Motoki Ueda from the RIKEN Center for Emergent Matter Science, who co-led the study alongside Yoshihiro Ito.
“Some of the problems that still need to be solved include low stability, short circulation times in the bloodstream, controlled drug release and poor targeting of tissue,” Ueda says. “I’m convinced that soft materials can overcome these problems.”
Lipid assemblies are soft materials that have many advantages as drug-delivery vesicles, including the ability to self-assemble, biocompatibility, biodegradation, phase transitions at useful temperatures and the ability to fuse to cell membranes. But vesicles made purely from lipids are too fragile to withstand for long the physical stresses encountered when traveling through the bloodstream.
Now, Ito, Ueda and their colleagues have created high-stability, drug-delivery vesicles by combining lipids with peptides—another soft material that has the ability to self-assemble. The hybrid vesicles consisted mainly of a tough peptide material interspersed with small patches of lipid.
“The peptide-rich areas make the hybrid vesicles highly stable,” says Ueda. The hybrid vesicles are more stable than lipid vesicles, retaining their shape and structural integrity when stored for a month at 4 degrees Celsius. “On the other hand, the lipid domain underwent a phase change from gel to liquid crystal.”
Image Credit: Alfred Pasieka
News This Week
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great day for science and humanity". [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. Jonathan F. Lovell, PhD, an [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three [...]
One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that [...]
Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative. But backers of a third type of test, developed by a Nobel Prize winner [...]
COVID-19 is a severe infectious disease that has claimed >150,000 lives and infected millions in the United States thus far, especially the elderly population. Emerging evidence has shown the virus to cause hemorrhagic and immunologic [...]
Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves. “We estimate that the capacity limit [...]
Scientists are to increase surveillance for new coronavirus mutations amid concerns that future strains of the virus could develop at least partial resistance to antibody treatments and Covid-19 vaccines. There is no evidence that the [...]